As of 2024-12-15, the Intrinsic Value of Corcept Therapeutics Inc (CORT) is
48.77 USD. This CORT valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 55.40 USD, the upside of Corcept Therapeutics Inc is
-12.00%.
The range of the Intrinsic Value is 30.50 - 143.40 USD
48.77 USD
Intrinsic Value
CORT Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
30.50 - 143.40 |
48.77 |
-12.0% |
| DCF (Growth 10y) |
37.40 - 165.37 |
58.19 |
5.0% |
| DCF (EBITDA 5y) |
13.86 - 26.18 |
17.86 |
-67.8% |
| DCF (EBITDA 10y) |
19.82 - 34.34 |
24.56 |
-55.7% |
| Fair Value |
10.39 - 10.39 |
10.39 |
-81.24% |
| P/E |
12.41 - 22.79 |
18.02 |
-67.5% |
| EV/EBITDA |
10.27 - 22.66 |
14.59 |
-73.7% |
| EPV |
14.51 - 17.47 |
15.99 |
-71.1% |
| DDM - Stable |
13.55 - 53.58 |
33.56 |
-39.4% |
| DDM - Multi |
16.21 - 50.19 |
24.55 |
-55.7% |
CORT Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
5,804.81 |
| Beta |
2.02 |
| Outstanding shares (mil) |
104.78 |
| Enterprise Value (mil) |
5,667.52 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.63% |
| Cost of Debt |
5.00% |
| WACC |
6.43% |